Resources

MDoutlook® Delivers Precision Intelligence

MDoutlook® introduces excerpts from an MDoutlook’s OncoScape™: Patient Segmentation and Referral Patterns for Advanced Lung Cancer in the US. This research is based on an on-line survey across multiple specialties, including oncologists, surgeons, primary care and emergency room physicians, that suspect and diagnose advanced lung cancer. OncoScape Methodology Primary research
Read more
On Friday, NPR had a very interesting and inspiring interview with Dr. Siddhartha Mukherjee, oncologist at Columbia University in New York. He has written a new article called The Improvisational Oncologist in this week's Sunday Magazine of the New York Times. In this article, he focuses on the emergence of
Read more
MDoutlook® are pleased to share excerpts from a recent MDoutlook’s OncoPulse™: Understanding Patient Pathways for mCRC in Europe. This analysis is based on an on-line survey of European oncologists managing (metastatic) Colorectal Cancer. OncoPulse Methodology Primary research phase involved European surveys to verified and validated medical oncologists with an identified
Read more
MDoutlook® is pleased to share excerpts from the most recent MDoutlook’s OncoPoll™: Clinical Impact of Recent Data Announcements in the treatment of Acute Myeloid Leukemia (AML). This research is the newest in a long line of impact studies following major data announcements in cancer. MDoutlook has covered the oncology space
Read more
MDoutlook is growing and is looking for qualified Global Medical Analysts to join our enthusiastic team of disease experts. You can access the job posting here. Direct your resume and cover letter to [email protected] (only candidates; no recruiters please). We look forward to adding new stars to our team!
Read more
Recently announced advances in the treatment of Multiple Myeloma (MM), for both newly diagnosed and relapsed / refractory patients, have been quickly embraced by oncologists globally. MDoutlook are pleased to share complimentary highlights from the most recent MDoutlook OncoPoll™: Clinical Impact of Recent Data Announcements in the treatment of Multiple
Read more
Speak with the cancer and commercialization experts at MDoutlook about answering your critical questions that arise throughout the life cycle of your brand or service. Oncology is an increasingly complex area, because of the rapidly evolving multi-disciplinary approach to disease management and the intricate diagnosis and treatment of this disease.
Read more
Since 2008, MDoutlook has built the largest panel of verified cancer treaters in the world. Now at over 95,000 members strong, MDoutlook uniquely identifies and targets oncologists and other physicians dedicated to the management of cancer. MDoutlook offers clients a range of services powered by this proprietary oncology panel to
Read more
MDoutlook is pleased to release the third report on the clinical impact of new data presented at ASCO and EHA 2015. This report includes analyses from 2 studies in hematologic malignancies involving more than 150 oncologists and hematologists with identified focus on Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM).
Read more
MDoutlook proudly presents the second study on the clinical impact of new data presented at ASCO 2015. This OncoPoll™ includes analyses from 2 studies in Gastrointestinal Cancers involving more than 160 oncologists. Our MD/PhD research team reports the following analysis highlights: Non-CRC GI Cancers Anti-PD-1 antibodies are expected to have
Read more
MDoutlook® introduces excerpts from an MDoutlook’s OncoScape™: Patient Segmentation and Referral Patterns for Advanced Lung Cancer in the US. This research is based on an on-line survey across multiple specialties, including oncologists, surgeons, primary care and emergency room physicians, that suspect and diagnose advanced lung cancer. OncoScape Methodology Primary research
Read more
On Friday, NPR had a very interesting and inspiring interview with Dr. Siddhartha Mukherjee, oncologist at Columbia University in New York. He has written a new article called The Improvisational Oncologist in this week's Sunday Magazine of the New York Times. In this article, he focuses on the emergence of
Read more
MDoutlook® are pleased to share excerpts from a recent MDoutlook’s OncoPulse™: Understanding Patient Pathways for mCRC in Europe. This analysis is based on an on-line survey of European oncologists managing (metastatic) Colorectal Cancer. OncoPulse Methodology Primary research phase involved European surveys to verified and validated medical oncologists with an identified
Read more
MDoutlook® is pleased to share excerpts from the most recent MDoutlook’s OncoPoll™: Clinical Impact of Recent Data Announcements in the treatment of Acute Myeloid Leukemia (AML). This research is the newest in a long line of impact studies following major data announcements in cancer. MDoutlook has covered the oncology space
Read more
MDoutlook is growing and is looking for qualified Global Medical Analysts to join our enthusiastic team of disease experts. You can access the job posting here. Direct your resume and cover letter to [email protected] (only candidates; no recruiters please). We look forward to adding new stars to our team!
Read more
Recently announced advances in the treatment of Multiple Myeloma (MM), for both newly diagnosed and relapsed / refractory patients, have been quickly embraced by oncologists globally. MDoutlook are pleased to share complimentary highlights from the most recent MDoutlook OncoPoll™: Clinical Impact of Recent Data Announcements in the treatment of Multiple
Read more
Speak with the cancer and commercialization experts at MDoutlook about answering your critical questions that arise throughout the life cycle of your brand or service. Oncology is an increasingly complex area, because of the rapidly evolving multi-disciplinary approach to disease management and the intricate diagnosis and treatment of this disease.
Read more
Since 2008, MDoutlook has built the largest panel of verified cancer treaters in the world. Now at over 95,000 members strong, MDoutlook uniquely identifies and targets oncologists and other physicians dedicated to the management of cancer. MDoutlook offers clients a range of services powered by this proprietary oncology panel to
Read more
MDoutlook is pleased to release the third report on the clinical impact of new data presented at ASCO and EHA 2015. This report includes analyses from 2 studies in hematologic malignancies involving more than 150 oncologists and hematologists with identified focus on Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM).
Read more
MDoutlook proudly presents the second study on the clinical impact of new data presented at ASCO 2015. This OncoPoll™ includes analyses from 2 studies in Gastrointestinal Cancers involving more than 160 oncologists. Our MD/PhD research team reports the following analysis highlights: Non-CRC GI Cancers Anti-PD-1 antibodies are expected to have
Read more